Furthermore, CD142 was significantly more highly expressed in severe COVID‐19 patients who underwent cannulation of suction and/or died, and by model analysis, they initially found that CD142 was 81.7% accurate as a prognostic predictor of COVID‐19, with high accuracy in excluding severe cases (Burrello et al., 2022). The gene discussed is F3; the disease is COVID-19.